floxuridine has been researched along with Biliary Tract Neoplasms in 4 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Biliary Tract Neoplasms: Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with an intrahepatic biliary hamartoma associated with transformation to undifferentiated carcinoma which responded to intrahepatic arterial floxuridine chemotherapy." | 7.70 | A cystic biliary tumour responding to regional fluorinated pyrimidine infusion. ( Allen-Mersh, TG; Burke, D; Hedayati, B; Shousha, S, 1998) |
| "We describe a patient with an intrahepatic biliary hamartoma associated with transformation to undifferentiated carcinoma which responded to intrahepatic arterial floxuridine chemotherapy." | 3.70 | A cystic biliary tumour responding to regional fluorinated pyrimidine infusion. ( Allen-Mersh, TG; Burke, D; Hedayati, B; Shousha, S, 1998) |
| " The pharmacokinetic analysis of gemcitabine and dFdU was performed with high-performance liquid chromatography-tandem mass spectrometry assay in cycles 1 and 2." | 1.35 | Pharmacokinetics of gemcitabine at fixed-dose rate infusion in patients with normal and impaired hepatic function. ( Citro, G; Cognetti, F; Colantonio, S; Contestabile, M; Di Segni, S; Felici, A; Milella, M; Nuvoli, B; Sacconi, A; Sperduti, I; Zaratti, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felici, A | 1 |
| Di Segni, S | 1 |
| Milella, M | 1 |
| Colantonio, S | 1 |
| Sperduti, I | 1 |
| Nuvoli, B | 1 |
| Contestabile, M | 1 |
| Sacconi, A | 1 |
| Zaratti, M | 1 |
| Citro, G | 1 |
| Cognetti, F | 1 |
| Curley, SA | 1 |
| Colleoni, M | 1 |
| Di Bartolomeo, M | 1 |
| Di Leo, A | 1 |
| Zilembo, N | 1 |
| Carnaghi, C | 1 |
| Pandolfi, A | 1 |
| Rimassa, L | 1 |
| Artale, S | 1 |
| Bajetta, E | 1 |
| Hedayati, B | 1 |
| Burke, D | 1 |
| Shousha, S | 1 |
| Allen-Mersh, TG | 1 |
1 review available for floxuridine and Biliary Tract Neoplasms
| Article | Year |
|---|---|
Update on regional treatments for hepatobiliary malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; | 1995 |
3 other studies available for floxuridine and Biliary Tract Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics of gemcitabine at fixed-dose rate infusion in patients with normal and impaired hepatic function.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Area Under Curve; Biliary Tract Neopla | 2009 |
Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancer.
Topics: Adult; Aged; Antidotes; Antineoplastic Agents; Biliary Tract Neoplasms; Drug Therapy, Combination; F | 1995 |
A cystic biliary tumour responding to regional fluorinated pyrimidine infusion.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract | 1998 |